Pre-market
Loading markets…

Advertisement

Stocks/TSX-V/GSD

Devonian Health Group Inc (GSD : TSX-V)

Common Stock

$8.50

CAD

+0.00 (%)

Last updated: 2026-07-28

Get GSD alerts:

GSD

Devonian Health Group Inc

Source:WealthAwesomeWealthAwesome
$1.51 (-15.08%)
30 day period
$5.10$8.50$11.90Apr 15Jul 6Jul 28

Performance

1 Day

+0.00%

1 Week

+9.68%

1 Month

-8.11%

YTD

-25.44%

Key Statistics

Market Cap

$23.64M

52W High

$15.00

52W Low

$0.19

P/E Ratio

-

50 Day MA

$9.60

200 Day MA

$11.13

Beta

1.26

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

Below 50 SMA

Price vs 200-Day SMA

Below 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
7/28/2026$8.49$8.51$8.49$8.50$8.504,408
7/27/2026$8.49$8.50$8.49$8.50$8.503,678
7/23/2026$7.50$7.50$7.50$7.50$7.50106
7/22/2026$7.75$7.75$7.75$7.75$7.751,900
7/21/2026$8.49$8.50$7.75$7.75$7.751,027
7/20/2026$7.00$9.00$7.00$9.00$9.002,120
7/17/2026$7.10$7.10$7.01$7.01$7.01321
7/15/2026$10.06$10.06$10.06$10.06$10.061,003
7/14/2026$10.14$10.14$10.14$10.14$10.14290
7/13/2026$7.26$7.26$7.00$7.00$7.001,806

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on GSD's historical volatility

HistoricalForecast68%95%
C$0.23C$44.54C$88.85C$133.17C$177.48C$221.79TodaySep 4Feb 23Jul 28Sep 9Oct 23Dec 5

30-Day Vol

285.4%

Annualized

90-Day Vol

198.1%

Annualized

Trend (90d)

-50.0%

Annualized drift

90d Mean

C$7.11

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$8.01C$2.99C$21.44
60 trading daysC$7.55C$1.88C$30.37
90 trading daysC$7.11C$1.29C$39.13

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Devonian Health Group Inc

Devonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine that is in phase 3 clinical trial for the treatment of Atopic dermatitis in adult population; in phase 2/3 clinical trial for Atopic dermatitis in pediatric population; in phase 2 clinical trial for HFS associated to chemotherapy; and in phase 2/3 clinical trial for Radiodermatitis associated to radiotherapy, as well as in phase 2a clinical trial for ulcerative colitis. The company also develops Pantoprazole Magnesium for the treatment of gastric reflux; Cleo-35 for the treatment of hormonal acne in women; R-Spinasome anti-aging cream, serum, and regenerating creams; and anti-aging products, including day, night, and eye creams under the Purgenesis name. Devonian Health Group Inc. is headquartered in Québec, Canada.

Financials

Revenue (TTM)
$3.00M
EBITDA
$-5.92M
Profit Margin
-204.08%
ROE (TTM)
-77.33%
EPS (Diluted)
-2.25
Book Value
2.51

Classification

Sector
Health Care
Industry
Biotechnology
Group
Pharmaceuticals, Biotechnology & Life Sciences

🔄 Recent Splits

1-for-60

Jan 22, 2026

Reverse

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About GSD

Market movers

Recent TSX-V movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
AUXXGold X2 Mining Inc.$6.60+522.64%
SMLSouthstone Minerals Ltd$0.05+66.67%
LMRLomiko Metals Inc$0.12+60.00%
IDLImaging Dynamics Company Ltd$0.07+50.00%
GELTangelo Games Corp$0.14+33.33%
MCFPinedale Energy Limited$0.02+33.33%
MSCMillennium Silver Corp$0.02+33.33%
PLO-HPaloma Resources Inc$0.02+33.33%

GSD.V news timeline

14 articles covering GSD.V, most recent first

Latest

Why Devonian Health Group Inc stock surged yesterday

Stocks

Advertisement